MIFH
PTCT icon

Migdal Insurance & Financial Holdings’s PTC Therapeutics PTCT Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,571
Closed -$501K – 654
2021
Q1 		$501K Buy
10,571
+6,560
+164% +$390K 0.01% 321
2020
Q4 		$245K Buy
+4,011
New +$236K ﹤0.01% 295

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Migdal Insurance & Financial Holdings's PTCT Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of PTC Therapeutics (PTCT) in Q2 2021, closing a stake of 10,571 shares — an estimated $501K sold.

Migdal Insurance & Financial Holdings first reported a position in PTCT in Q4 2020 and held it in 2 quarters. The position peaked at $501K in Q1 2021. 183 funds tracked by Wall St. Rank hold PTCT as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining PTC Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 10,571 PTC Therapeutics shares in Q2 2021, an estimated $501K.
  • Migdal Insurance & Financial Holdings first reported a position in PTC Therapeutics in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's PTC Therapeutics position peaked at $501K in Q1 2021.
  • 183 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.